Brokers Set Expectations for VERA FY2026 Earnings
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Vera Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos anticipates that the company will post earnings per share of ($2.28) for the […]
